LFB Biomanufacturing
David Olivas has extensive experience in the pharmaceutical industry, currently serving as Responsable Assurance Qualité at LFB Biomanufacturing since March 2008. Prior to this role, David worked as Pharmacien de production at LFB from July 2000 to September 2004. David Olivas earned a Docteur en Pharmacie degree from Faculté de pharmacie, completing studies from 1989 to 1995.
LFB Biomanufacturing
LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing is subsidiary of the LFB Group.